274 related articles for article (PubMed ID: 10419600)
1. Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn's disease increases detectability of the MUC2 protein core.
Hanski C; Born M; Foss HD; Marowski B; Mansmann U; Arastéh K; Bachler B; Papenfuss M; Niedobitek F
J Pathol; 1999 Jul; 188(3):304-11. PubMed ID: 10419600
[TBL] [Abstract][Full Text] [Related]
2. Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis.
Gersemann M; Becker S; Kübler I; Koslowski M; Wang G; Herrlinger KR; Griger J; Fritz P; Fellermann K; Schwab M; Wehkamp J; Stange EF
Differentiation; 2009 Jan; 77(1):84-94. PubMed ID: 19281767
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of MUC2 synthesis in ulcerative colitis.
Tytgat KM; van der Wal JW; Einerhand AW; Büller HA; Dekker J
Biochem Biophys Res Commun; 1996 Jul; 224(2):397-405. PubMed ID: 8702401
[TBL] [Abstract][Full Text] [Related]
4. Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease.
Autschbach F; Giese T; Gassler N; Sido B; Heuschen G; Heuschen U; Zuna I; Schulz P; Weckauf H; Berger I; Otto HF; Meuer SC
Virchows Arch; 2002 Nov; 441(5):500-13. PubMed ID: 12447682
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
6. Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease.
Krishna M; Woda B; Savas L; Baker S; Banner B
Mod Pathol; 1995 Aug; 8(6):654-7. PubMed ID: 8532700
[TBL] [Abstract][Full Text] [Related]
7. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection.
Van der Sluis M; De Koning BA; De Bruijn AC; Velcich A; Meijerink JP; Van Goudoever JB; Büller HA; Dekker J; Van Seuningen I; Renes IB; Einerhand AW
Gastroenterology; 2006 Jul; 131(1):117-29. PubMed ID: 16831596
[TBL] [Abstract][Full Text] [Related]
8. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of chemokines (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis.
Jugde F; Alizadeh M; Boissier C; Chantry D; Siproudhis L; Corbinais S; Quelvennec E; Dyard F; Campion JP; Gosselin M; Bretagne JF; Sémana G; Heresbach D
Eur Cytokine Netw; 2001; 12(3):468-77. PubMed ID: 11566628
[TBL] [Abstract][Full Text] [Related]
10. Expression of macrophage-colony stimulating factor in normal and inflammatory bowel disease intestine.
Klebl FH; Olsen JE; Jain S; Doe WF
J Pathol; 2001 Dec; 195(5):609-15. PubMed ID: 11745698
[TBL] [Abstract][Full Text] [Related]
11. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis.
Yantiss RK; Das KM; Farraye FA; Odze RD
Am J Surg Pathol; 2008 Jun; 32(6):844-50. PubMed ID: 18408596
[TBL] [Abstract][Full Text] [Related]
12. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
[TBL] [Abstract][Full Text] [Related]
13. Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis.
Lampinen M; Backman M; Winqvist O; Rorsman F; Rönnblom A; Sangfelt P; Carlson M
J Leukoc Biol; 2008 Dec; 84(6):1392-9. PubMed ID: 18801925
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease.
Katsuta T; Lim C; Shimoda K; Shibuta K; Mitra P; Banner BF; Mori M; Barnard GF
Am J Gastroenterol; 2000 Nov; 95(11):3157-64. PubMed ID: 11095335
[TBL] [Abstract][Full Text] [Related]
15. Biopsy histamine in ulcerative colitis and Crohn's disease.
Baenkler HW; Lux G; Günthner R; Kohlhäufl M; Matek W
Hepatogastroenterology; 1987 Dec; 34(6):289-90. PubMed ID: 3428863
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha.
Wu F; Zikusoka M; Trindade A; Dassopoulos T; Harris ML; Bayless TM; Brant SR; Chakravarti S; Kwon JH
Gastroenterology; 2008 Nov; 135(5):1624-1635.e24. PubMed ID: 18835392
[TBL] [Abstract][Full Text] [Related]
17. Localization and up-regulation of mucin (MUC2) gene expression in human nasal biopsies of patients with cystic fibrosis.
Li D; Wang D; Majumdar S; Jany B; Durham SR; Cottrell J; Caplen N; Geddes DM; Alton EW; Jeffery PK
J Pathol; 1997 Mar; 181(3):305-10. PubMed ID: 9155717
[TBL] [Abstract][Full Text] [Related]
18. Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease.
Strugala V; Dettmar PW; Pearson JP
Int J Clin Pract; 2008 May; 62(5):762-9. PubMed ID: 18194279
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase.
Akazawa A; Sakaida I; Higaki S; Kubo Y; Uchida K; Okita K
J Gastroenterol; 2002; 37(5):345-53. PubMed ID: 12051533
[TBL] [Abstract][Full Text] [Related]
20. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
Banks C; Bateman A; Payne R; Johnson P; Sheron N
J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
